Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_assertion type Assertion NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_head.
- NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_assertion description "[The clinical relevance of these findings is strongly supported since TCD-717 has recently entered Phase I clinical trials against solid tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_provenance.
- NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_assertion evidence source_evidence_literature NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_provenance.
- NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_assertion SIO_000772 23762272 NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_provenance.
- NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_assertion wasDerivedFrom befree-2016 NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_provenance.
- NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_assertion wasGeneratedBy ECO_0000203 NP1085549.RApMoAN6gEI9Z35dhHOK_-Fd4dikARF9gAwbWqaiJCj2c130_provenance.